HOME >> BIOLOGY >> NEWS
Combination therapy drives cancer into remission

Researchers have achieved an experimental breakthrough in the simultaneous use of two or more agents for treating cancer, known as combination therapy. If it is shown to be safe and effective in humans, the therapy outlined by the new study is a promising general strategy for treating many cancers that do not respond to current therapies.

A two-drug combination therapy, published in tomorrow's issue of the journal Nature, led to the complete remission of a mouse model of B-cell lymphoma in all of the treated animals. In contrast, animals treated with either drug alone (rapamycin or doxorubicin) rarely experienced complete remission.

The study, led by Dr. Scott Lowe of Cold Spring Harbor Laboratory, establishes a new paradigm for overcoming chemotherapy resistance in many forms of cancer.

Rational Target Selection and an Off-the-Shelf Chemotherapeutic "One-Two Punch" for Lymphoma and Other Cancers

Pre-cancerous cells can be eliminated from the body by a natural self-destruct mechanism--normally active in many types of cells--called programmed cell death. Unfortunately, a hallmark of most cancers is a defect in programmed cell death that enables pre-cancerous cells to survive, proliferate out of control, and form a tumor.

Because most traditional chemotherapy agents act by triggering programmed cell death, such agents are frequently ineffective against tumors that lack a functional programmed cell death mechanism. Such tumors are said to be chemotherapy-resistant. The evasion of treatment-induced programmed cell death by chemotherapy-resistant tumors has been a major impediment to successful therapeutic outcomes for human cancer.

Lowe and his colleagues reasoned that--like a one-two knockout punch in boxing--using one drug to restore the programmed cell death mechanism and a second drug to trigger the process might reduce or eliminate chemotherapy-resistance and be an effective strategy for treating cancer.
'"/>

Contact: Jeff Picarello
picarell@cshl.edu
516-367-8486
Cold Spring Harbor Laboratory
17-Mar-2004


Page: 1 2 3 4

Related biology news :

1. Combination of gene therapy and gene silencing prevents neurodegenerative disease
2. Combination therapy dramatically improves function after spinal cord injury in rats
3. Combination drug therapy drastically reduces multiple coronary heart disease risk factors
4. Combination therapy improves anthrax survival
5. Drug Combination May Prove Effective To Prevent Recurrence Of Hepatitis C After Transplantation
6. Combination Therapy For Brain Tumors Holds Promise For Longer Survival After Surgery
7. New Heart-Attack Indicator Dramatically Improves Diagnostic Accuracy Of ER Doctors: TnT/Echocardiogram Combination Could Reduce Needless Admissions
8. Dangerous Chemical Combination Presents Possible Scenario For Gulf War Illnesses
9. Targeted therapy knocks out pediatric brain cancer in mice
10. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
11. Columbia research to examine gene influence on severity of peridontal disease, therapy response

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/5/2020)... ... 05, 2020 , ... Diagenode, a leading global provider of ... subsidiary of global genomics leader BGI Group, today announced a co-marketing agreement for ... Asia Pacific. , Under the terms of the non-exclusive agreement, the two ...
(Date:3/4/2020)... ... 2020 , ... RoosterBio Inc., a leading supplier of human ... a significant milestone in the regenerative medicine field with the dosing of the ... by RoosterBio’s pharmaceutical customer with an Investigational New Drug (IND) that was manufactured ...
(Date:3/2/2020)... (PRWEB) , ... March 02, 2020 , ... Nominations are ... program co-founded by the Security Industry Association (SIA) and SecureIDNews ... SIA Women in Security Forum . The recipients of this year’s Women in Biometrics ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... ... February 20, 2020 , ... ... capability to perform complex, efficient and elegant chemistry. Humans have been increasingly ... our own goals. , Through rapidly evolving technologies and strategies for modern ...
(Date:2/19/2020)... ... February 18, 2020 , ... ... characterizing microbiome populations down to the strain level, recently unveiled a novel DNA ... for efficient and unbiased isolation of high molecular weight (HMW) single-stranded DNA (ssDNA) ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... results from a long-term follow-up clinical study of outpatient L4-L5 lumbar interspinous ... LLC). Unlike extension block design, the Inspan device fixates the spine to ...
(Date:2/5/2020)... ... February 05, 2020 , ... Rare Disease Day® ... by The National Organization for Rare Disorders (NORD), to raise awareness amongst the general ... ). The Balancing Act’s “Behind The Mystery” rare disease series will be ...
Breaking Biology Technology:
Cached News: